Neurol India Home 
 

REVIEW ARTICLE
Year : 2017  |  Volume : 65  |  Issue : 7  |  Page : 60--70

Management of brain tumor-related epilepsy

Neil V Klinger1, Aashit K Shah2, Sandeep Mittal3 
1 Department of Neurosurgery, Wayne State University School of Medicine, Detroit, Michigan, USA
2 Department of Neurology, Wayne State University School of Medicine; Comprehensive Epilepsy Center, Detroit Medical Center and Wayne State University, Detroit, Michigan, USA
3 Department of Neurosurgery; Oncology, Wayne State University School of Medicine; Comprehensive Epilepsy Center, Detroit Medical Center and Wayne State University; Multidisciplinary Neuro-Oncology Program, Karmanos Cancer Institute, Detroit, Michigan, USA

Correspondence Address:
Sandeep Mittal
Department of Neurosurgery, Wayne State University, 4160 John R Street, Suite 930, Detroit, Michigan - 48201
USA

Seizures are common in both primary and metastatic brain tumors, although the rate of seizures differ significantly between the different types of neoplasms. Patients with brain tumor-associated seizures need treatment with antiepileptic drugs (AEDs) to prevent recurrence, whereas strong clinical data exists to discourage routine prophylaxis in patients who have not had seizures. The newer AEDs, such as levetiracetam, lamotrigine, lacosamide, topiramate, or pregabalin, are preferable for various reasons, primarily related to the side-effect profile and limited interactions with other drugs. If seizures persist despite initiation of an appropriate monotherapy (in up to 30–40% of cases), additional anticonvulsants may be necessary. Early surgical intervention improves seizure outcomes in individuals with medically refractory epilepsy, especially in patients with a single lesion that is epileptogenic. Data for this review article were compiled by searching for scholarly articles using the following keywords: brain tumor, epilepsy, seizure, tumor-related epilepsy, central nervous system, epidemiology, review, clinical trial, and surgery. Articles were screened for relevance by title and abstract, and selected for review and inclusion based on significant contribution to the topics discussed.


How to cite this article:
Klinger NV, Shah AK, Mittal S. Management of brain tumor-related epilepsy.Neurol India 2017;65:60-70


How to cite this URL:
Klinger NV, Shah AK, Mittal S. Management of brain tumor-related epilepsy. Neurol India [serial online] 2017 [cited 2021 May 9 ];65:60-70
Available from: https://www.neurologyindia.com/article.asp?issn=0028-3886;year=2017;volume=65;issue=7;spage=60;epage=70;aulast=Klinger;type=0